Caxton Associates (New York)’s PetMed Express PETS Stock Holding History

Caxton Associates (New York)’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,771	Closed	-$531K	–	649
2021 Q3	$531K	Buy	19,771 +6,089	+45%	+$175K	0.06%	192
2021 Q2	$436K	Buy	13,682 +2,872	+27%	+$91.2K	0.05%	209
2021 Q1	$380K	Buy	+10,810	New	+$376K	0.03%	216
2020 Q3	–	Sell	-17,763	Closed	-$633K	–	465
2020 Q2	$633K	Buy	+17,763	New	+$617K	0.06%	103
2018 Q2	–	Sell	-5,066	Closed	-$212K	–	456
2018 Q1	$212K	Hold	5,066	–	–	0.01%	310
2017 Q4	$231K	Buy	+5,066	New	+$200K	0.01%	318

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Caxton Associates (New York)'s PETS Position: Q4 2021 in Review

Caxton Associates (New York) sold out of PetMed Express (PETS) in Q4 2021, closing a stake of 19,771 shares — an estimated $531K sold.

Caxton Associates (New York) first reported a position in PETS in Q4 2017 and held it in 6 quarters. The position peaked at $633K in Q2 2020. 182 funds tracked by Wall St. Rank hold PETS as of Q4 2021.

Caxton Associates (New York) reported no remaining PetMed Express position as of Q4 2021 after selling out during the quarter.
Caxton Associates (New York) sold 19,771 PetMed Express shares in Q4 2021, an estimated $531K.
Caxton Associates (New York) first reported a position in PetMed Express in Q4 2017 and held it in 6 quarters.
Caxton Associates (New York)'s PetMed Express position peaked at $633K in Q2 2020.
182 funds tracked by Wall St. Rank held PetMed Express as of Q4 2021.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.